Palo Alto, Calif.-based startup Symphonyrm reported picking up $10 million in series A financing, led by Adam Street Partners, to help accelerate its growing investment in its artificial intelligence (AI) algorithms and consumer relationship management platform.

MELBOURNE, Australia – Australia's medical device regulations are undergoing the most extensive changes to the regulations in the last three decades, a top Therapeutic Goods Administration (TGA) official told the AusMedTech conference. That revolutionary rate of change, however, ground to a halt in the last five weeks leading up to the country's national election, with the government now in "caretaker mode," TGA Health Products Regulation Group Deputy Secretary John Skerritt said.

PARIS – Six months after floating on the Euronext stock exchange in Paris, Predilife SA from Villejuif, France, is launching the Mammorisk predictive test for breast cancer risk in Europe and the U.S. "Mammorisk is the first multi-criteria test to use data mining, allowing it to combine medical imaging, genetic profile and family history," Pierre Verdet, assistant managing director of Predilife, told BioWorld MedTech.